Tumor-associated leukocytes (TALs) have previously been associated with favorable prognosis in CRC, particularly when the density and distribution of CD8+ and CD45RO+ memory T cells are assessed [9, 12]. This evidence concerns the gene CD8A and colorectal carcinoma.